ADx presents at ADPD results on VAMP2, a new synaptic biomarker showing significant changes in very early pre-clinical disease state. NewsEvents ADx presents at ADPD results on VAMP2, a new synaptic biomarker showing significant changes in very early pre-clinical disease state.
